Leaderboard

En | De
Sie sind hier: Onkologie » Gynäkologische Tumoren 22. Juni 2026
Suchen
medline.ch
Gynäkologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 16526  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 330517  
   
Elevated ESR2 and BRCA1 gene expression in adenomyosis associated with endometrial cancer: a pilot study.
Gynecol Endocrinol
La Torre F, Nardi E, Bonechi F, Vannuccini S, Sorbi F, Fambrini M, Castiglione F, Zannoni GF, Morandi A, Reis FM, Petraglia F.
PMID: 42329179 [PubMed - indexed for MEDLINE]


Targeting the JAK/STAT pathway with isoliquiritigenin in ovarian cancer: molecular mechanisms and therapeutic implications.
Front Pharmacol
Ding M, Guo F, Lin P.
PMID: 42328651 [PubMed]


The Role of Angiogenesis in Breast Cancer and Obesity: Unravelling the Connection.
Int J Breast Cancer
Sikuza YOK, Basson C, Oberholzer N, Ambele MA.
PMID: 42328208 [PubMed]


Second primary driver-negative lung adenocarcinoma following breast cancer treatment: a case report.
Pan Afr Med J
Khadrouf Z, Khadiri K, Benmessaoud H, Essalihi A, Bouchra O, Benchekrou MT, Amarir F, Naya A, Karkouri M.
PMID: 42328027 [PubMed - indexed for MEDLINE]


Adjuvant chemotherapy combined with pembrolizumab immunotherapy for primary triple-negative neuroendocrine carcinoma of the breast: a case report and literature review.
Front Immunol
Shen X, Yang J, Du Y, Fu D.
PMID: 42327776 [PubMed - in process]


Association Between Coffee and Caffeine Intake and Risk of Breast Cancer: A Systematic Review and Meta-Analysis of Cohort Studies.
Health Sci Rep
Karimi M, Ghaemi S, Goudarzi R, Karimi MA, Kazemi K, Haghshenas H, Asbaghi O.
PMID: 42327457 [PubMed]


Exploring the Role of HER1 and HER2 Gene Variants in Breast Cancer Susceptibility: A Case-Control Study in Bangladesh.
Health Sci Rep
Tabassum R, Abid AA, Shithi SSI, Islam S, Rafique URB, Shultana S, Mohiuddin M, Tanjum S, Haque MA.
PMID: 42327455 [PubMed]


SiNuS: A comprehensive dataset for singular nuclei segmentation for HER2 grading of breast cancer.
Data Brief
Hossain MS, Rahman MS, Ahmed M.
PMID: 42327358 [PubMed]


Effects of Resistance Training on Breast Cancer-Related Lymphedema: A Meta-Analysis.
Arch Rehabil Res Clin Transl
Wu S, Zhong C, Liu Z.
PMID: 42326594 [PubMed]


Evaluating the efficacy and safety of first-line immunotherapy for metastatic triple-negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials with a focus on PD-L1 expression.
Front Oncol
Sun Y, Zhang L, Guo D.
PMID: 42326340 [PubMed]


Exercise in regional breast cancer with neoadjuvant anthracycline-based chemotherapy with immune checkpoint-inhibition: study protocol for a prospective randomised controlled trial.
Front Oncol
Murr E, Grill S, Kiechle M, Kraemer A, Madl B, Glowka S, Haller B, Fiorentini C, Adjej E, Haykowsky MJ, Halle M, Wernhart S.
PMID: 42326337 [PubMed]


Development and validation of a machine learning-based risk prediction model for cancer-related fatigue in ovarian cancer patients.
Front Oncol
Feng R, Fan Z, Pang Y, Ding Q, Yue Q, Wei S.
PMID: 42326332 [PubMed]


A prediction model and risk stratification tool for survival by chemotherapy in invasive micropapillary carcinoma of the breast: a population-based study with external validation.
Front Oncol
Yang F, Yang Y, Xu Q, Tang L, Wang Y, Cathcart-Rake EJ, Xie L.
PMID: 42326317 [PubMed]


Expression of the Cystatin SN (CST1) in Breast Cancer and Its Association With Clinical Characteristics: A Cross-Sectional Study.
Cureus
Najnin S, Chowdhury NS, Ferdous R, Paul P, Islam J, Rahman MH.
PMID: 42326300 [PubMed]


Predictors of Pathological Complete Response and Patient-Reported Outcomes During Neoadjuvant Chemotherapy in Early Breast Cancer: A Single-Center Retrospective Cohort Study.
Cureus
Komporaly IA, Gheorghe AS, Iovanescu EA, Kajanto LA, Georgescu B, Stanculeanu D.
PMID: 42326181 [PubMed]


Unmasking the Myositis: A Diagnostic Clue to Occult Breast Cancer.
Cureus
Naga Siri K, Ambalathandi RC, Ravel N, Lakshmi R.
PMID: 42326105 [PubMed]


A multimodal ultrasound-based model combining tumor radiomics and axillary lymph node morphologic classification for predicting axillary nodal burden in breast cancer.
Front Endocrinol (Lausanne)
Lu R, Yang T, Pan L, Shao L, Zhang L, Sun F, Du J, Zhao L.
PMID: 42325623 [PubMed - indexed for MEDLINE]


IGF-II, IGFBP-4, -6, and -7, and HMGB1 show changes in follicular fluid in PCOS.
Front Endocrinol (Lausanne)
Buia V, Catellani C, Croci S, Righi B, Morini D, Falbo AI, Nicoli A, De Fanti A, Belloni L, Aguzzoli L, Villani MT, Sartori C, Street ME.
PMID: 42325612 [PubMed - indexed for MEDLINE]


Dynamic vitamin D trajectories and their prognostic value in breast cancer: a group-based trajectory modeling study.
Front Nutr
Yin LB, Lan XL, Chen T, Zhang J, Zheng Y.
PMID: 42325518 [PubMed]


Exosomes in Ovarian Cancer: Promoters, Biomarkers, and Therapeutic Targets.
Int J Nanomedicine
Wang F, Dong H, Song Y, Zhang Y.
PMID: 42325396 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 330517    Seite 1 von 16526  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1